Pulmonx
Kathy Wilkie, CPC, CM, CMT, has extensive experience in healthcare management and coding, currently serving as a Case Manager at Pulmonx Corporation since July 2019. Kathy's previous roles include positions such as Revenue Cycle-Complex Coder/Auditor at Henry Ford Health System, HCC Auditor at UnitedHealth Group, and Case Manager at The Reimbursement Group. Additionally, Kathy was the Owner of Michigan Muscular Therapy Rehab, demonstrating entrepreneurial skills in the healthcare sector. Educational credentials include a degree in Muscular Therapy from Wellsprings Institute, complemented by a background in compliance coding and surgical coding specialist roles at IHA and related organizations.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1